GetSeriousOK
3 weeks ago
I think you're upset because your .095 bids are getting buried by higher bids.
I want to buy under .10 too, but if I can't, I can't -- I consider that to be a bullish sign.
There might be some dumping yet this year from GPB Holdings -- the GPB parent company, GPB Capital, went into Receivership, and GPB Holdings owns a lot of GTHP common stock. Hard to tell how that will affect GTHP if at all, but if that ends up causing dumping you'll probably get your .095 bids filled.
myjog
4 weeks ago
There you go! It’s Deja-vu all over again. Whenever stock tries to go up slightly relatively heavy selling brings it down. Stock’s bid neither increasing nor there appears to be any buying interest in the stock. There are sellers & only sellers for this stock. This is because management is not giving the most important & relevant information about the business. Whether management is doing this deliberately & purposely, is anybody’s guess. When any company’s stock is thinly traded or illiquid or there’s selling pressure on the stock, usually that means market’s perception about management being incompetent, inept, lazy & dishonest. What are management’s vested interests in not publishing the most important & relevant information about company & it’s business thus helping manipulative broker-dealers/market-makers in keeping stock price subdued, is anybody’s guess.
GetSeriousOK
1 month ago
The dividends are legally contracted dividends. The managers are entitled to those dividends.
Why do you say the Officers are "not doing their job?" I think they ARE doing their job. What specifically do you think they are not doing?
And how are the Officers "using stock as their personal piggy bank?" They aren't selling stock.
The Officers are personally and almost single-handedly funding the company during this down-time as we wait for the US clinicals to finish. They aren't borrowing from hedgies or toxic lenders, and their loans have warrants for 0.25 -- well above the current PPS. Because of the absence of toxic funding, the O/S and float are still exceptionally low: the O/S is still under 60 million and the float is under 25 million. I like that. You don't?
Regarding SMI: I don't think anyone ever believed that SMI would accomplish anything. They DID accomplish something, to my surprise: they completed a 400-patient clinical trial in China run by noted physicians, and that trial had better-than-expected results. That's a win for Guided, even though SMI will likely never submit anything to the NMPA. You are correct that SMI hasn't made their scheduled payments to Guided, but I never expected them to. You did, apparently? Honestly?
I believe that a different entity can submit the application to the NMPA. You don't believe that? It would require negotiations and new agreements, most likely involving Shenghuo, but I don't see that as a negative for Guided.
Try to answer without your usual hyperbole -- give concrete responses to defend your assertions. Thanks in advance.